Companies /Healthcare

Teva- Pharmaceutical Industries Ltd

NYSE: TEVA Drug Manufacturers - Specialty & Generic
$36.62
▼ $0.87 (−2.32%) today
Markets closed · 2:27am ET

TEVA Coverage

Page 30
12:17pm ET
Health and Healthcare

Biotech Business Daily (GSK, MRK, OMPI, STEM, TEVA, VNDA)

Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China, Russia, Brazil,…

Douglas A. McIntyre
11:23am ET
Health and Healthcare

Biotech Busine$$ Daily (BNT, TEVA, BPAX, NCST, RPRX, VRTX)

Bentley Pharmaceuticals Inc. (NYSE: BNT) will be purchased by Teva Pharmaceutical Industries (NASDAQ: TEVA) for $360 million. Bentley shareholders will receive $15 per share and an undisclosed amount of shares in CPEX…

Douglas A. McIntyre
10:11am ET
Health and Healthcare

Teva’s Lofty Goals Seem Attainable (TEVA)

Teva Pharmaceutical (NASDAQ: TEVA – News) has some pretty loft goals for itself at its Investor Day presentation.  If you trust the company’s history and its pipeline of candidates under trials and…

Douglas A. McIntyre
7:49am ET
Health and Healthcare

Teva Beats & Grows, Shares Off (TEVA)

Teva Pharmaceuticals (NASDAQ: TEVA) posted earnings at $0.69 EPS on revenues of $2.58 Billion; First Call had consensus at $0.66 EPS on $2.48 Billion in revenues. There are some big numbers ahead…

Douglas A. McIntyre
6:40am ET
Investing

Early Research Calls 7/9/2007

Bear Stearns Upgrades PCAR to outperform. Think Equity downgrades YHOO to accumulate. LXK cuts guidance for Q2. TEVA upgraded to outperform at Bear Strearns. ESV downgraded to underperform at Credit Suisse. GOOG…

Douglas A. McIntyre
6:30am ET
Investing

Earlybird Analyst Calls (June 6, 2007)

AGN started as Buy at Jefferies.AW started as Outperform at Credit Suisse.BAY started as Overweight at JPMorgan.CACH cut to Neutral at Merriman Curhan Ford.CIEN started as Outperform at Piper Jaffray.CPNO started as…

Douglas A. McIntyre
11:21am ET
Health and Healthcare

Mylan’s Shareholders Act As LBO Lenders

Mylan Labs (MYL-NYSE) is seeing its shares take a beating because it is acquiring Merck KGaA’s generic unit and Mylan is the acquirer in what is a very leveraged buyout.  It isn’t…

Douglas A. McIntyre